Song Ruilin

Song Ruilin is Executive President of China Pharmaceutical Innovation and Research Development Association (PhIRDA), a non-profit organization that represents the research-based pharmaceutical industry in China. It serves as a bridge between the Chinese pharmaceutical industry and the government, promoting innovation, ethics, and international collaboration.

Professor Song is an Expert of Talent Pool for State Affairs of the Chinese People's Political Consultative Conference (CPPCC), an Advisor on Participation in and Deliberation of State Affairs for the Central Committee of the Chinese Peasants and Workers Democratic Party, and Chairman of iMeta Health Information Consulting Co., Ltd, a consulting and service provider for the entire pharmaceutical industry value chain.

Professor Song obtained an L.L.B. from the China University of Political Science and Law, an EMBA from the China Europe International Business School, a Doctor of Social and Administrative Pharmacy from China Pharmaceutical University, and is a Visiting Scholar of the University of Sydney. He served in the Legislative Affairs Office of the State Council of China for a number of years, engaging in health and drug policy, legal studies, and was in charge of law making and reviewing in the areas of pharmaceuticals and the healthcare industry. In recent years, he mainly engages in research on China's pharmaceutical innovation policy.

Currently, Professor Song also serves as Executive Deputy Director of the Research Center of National Drug Policy & Ecosystem at China Pharmaceutical University, Visiting Research Fellow a Shanghai Jiao Tong University, a Member of the TCM Strategic Expert Consultation Committee of NMPA, Biotech Advisory Panel Member of the SEHK, Vice President of China Alliance for Rare Disease (CARD), Honorary Director of Chinese Pharmaceutical Association (CPA), Director of Chinese Pharmacists Association, and Director of the Bethune Charitable Foundation.